New ultraviolet C light‐based method for pathogen inactivation of red blood cell units
- 10 September 2022
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 62 (11) , 2314-2323
Abstract
Background: Pathogen inactivation (PI) technologies for platelet concentrates and plasma are steadily becoming more established, but new PI treatment options for red blood cells (RBCs), the most commonly used blood component, still need to be developed. We present a novel approach to inactivating pathogens in RBC units employing ultraviolet C (UVC) light.Methods: Whole blood‐derived leukoreduced RBCs suspended in PAGGS‐C, a third generation additive solution, served as test samples, and RBCs in PAGGS‐C or SAG‐M as controls. Vigorous agitation and hematocrit reduction by diluting the RBCs with additional additive solution during illumination ensured that UVC light penetrated and inactivated the nine bacteria and eight virus species tested. Bacterial and viral infectivity assays and in vitro analyses were performed to evaluate the system's PI capacity and to measure the RBC quality, metabolic, functional, and blood group serological parameters of UVC‐treated versus untreated RBCs during 36‐day storage.Results: UVC treatment of RBCs in the PAGGS‐C additive solution did not alter RBC antigen expression, but significantly influenced some in vitro parameters. Compared to controls, hemolysis was higher in UVC‐treated RBC units, but was still below 0.8% at 36 days of storage. Extracellular potassium increased early after PI treatment and reached ≤70 mmol/L by the end of storage. UVC‐treated RBC units had higher glucose and 2,3‐diphosphoglycerate levels than controls.Conclusion: As UVC irradiation efficiently reduces the infectivity of relevant bacteria and viruses while maintaining the quality of RBCs, the proposed method offers a new approach for PI of RBC concentrates.Keywords
This publication has 31 references indexed in Scilit:
- Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell ConcentratesTransfusion Medicine and Hemotherapy, 2011
- UVC Irradiation for Pathogen Reduction of Platelet Concentrates and PlasmaTransfusion Medicine and Hemotherapy, 2011
- Modeling the risk of an emerging pathogen entering the Canadian blood supplyTransfusion, 2010
- Influence of late irradiation on the in vitro RBC storage variables of leucoreduced RBCs in SAGM additive solutionVox Sanguinis, 2010
- Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trialsTransfusion, 2008
- Pathogen inactivation: making decisions about new technologiesTransfusion, 2007
- Therapeutic efficacy and safety of red blood cells treated with a chemical process (S‐303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patientsTransfusion, 2005
- The viability of autologous human red cells stored in additive solution 5 and exposed to 25°C for 24 hoursTransfusion, 1999
- A Method for Determination of Hemoglobin in Plasma by Near-Ultraviolet SpectrophotometryScandinavian Journal of Clinical and Laboratory Investigation, 1959
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedeberg's Archives of Pharmacology, 1931